FDA Inspection 1316646 — Element Materials Technology Boston - Acton Inc.

Element Materials Technology Boston - Acton Inc. — FEI 1000148174

The FDA completed an inspection of Element Materials Technology Boston - Acton Inc. on May 4, 2026 in Acton, MA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 4 citations were issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 4, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Acton, MA (United States)

Citations

IDCFRDescription
143421 CFR 211.42(c)(10)(iv)Environmental Monitoring System
202721 CFR 211.192Investigations of discrepancies, failures
354721 CFR 211.46(b)Equipment for Environmental Control
356521 CFR 211.58Buildings not maintained in good state of repair